TLDR:
- Indianapolis venture capital firm VisionTech Angels invested $2.88 million in 2023, nearly half a million more than the previous year.
- The company participated in 18 deals and had three successful exits.
Indianapolis venture capital firm VisionTech Angels announced that it invested $2.88 million in 2023, which is almost half a million dollars more than the previous year. The company participated in 18 deals and had three successful exits with positive returns for investors in Allotrope, Smart Apply, and Smart File. VisionTech Angels also added eight new portfolio companies to its roster, including Adipo Therapeutics, Amplified Sciences, FiberX, Laxis, Mentavi Health, NuvOx Therapeutics, Pelvital USA, and Primary Record. The company focused on startup leadership in 2023 and highlighted the success of Amplified Sciences CEO Diana Caldwell, who secured $165,000 from 21 investors during its fundraising round. VisionTech Angels expects valuations to continue to shift lower and be more favorable to investors and believes that exit windows will open up. The firm believes that portfolio companies that survived 2023 are those with cash flow to carry them into the new year.
